1. Home
  2. KEEL vs IOVA Comparison

KEEL vs IOVA Comparison

Compare KEEL & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Keel Infrastructure Corp. Common Stock

KEEL

Keel Infrastructure Corp. Common Stock

N/A

Current Price

$4.00

Market Cap

1.9B

Sector

Finance

ML Signal

N/A

Logo Iovance Biotherapeutics Inc.

IOVA

Iovance Biotherapeutics Inc.

HOLD

Current Price

$4.13

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KEEL
IOVA
Founded
N/A
2007
Country
Canada
United States
Employees
274
N/A
Industry
Finance: Consumer Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
1.7B
IPO Year
N/A
2008

Fundamental Metrics

Financial Performance
Metric
KEEL
IOVA
Price
$4.00
$4.13
Analyst Decision
Buy
Analyst Count
0
10
Target Price
N/A
$9.00
AVG Volume (30 Days)
29.0M
15.7M
Earning Date
N/A
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
14.84
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$47.74
Revenue Next Year
N/A
$40.31
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.17
$1.76
52 Week High
$7.37
$5.64

Technical Indicators

Market Signals
Indicator
KEEL
IOVA
Relative Strength Index (RSI) 37.79 42.64
Support Level $3.41 $3.77
Resistance Level $5.03 $4.45
Average True Range (ATR) 0.43 0.42
MACD 0.01 -0.08
Stochastic Oscillator 40.70 19.95

Price Performance

Historical Comparison
KEEL
IOVA

About KEEL Keel Infrastructure Corp. Common Stock

Keel Infrastructure Corp is a North American digital infrastructure and energy company that develops and owns data centers and energy infrastructure for high-performance computing workloads, including AI. The group has a pipeline of 2.2 gigawatts and established grid interconnections already in place. It delivers scalable infrastructure solutions in high-demand power markets across Pennsylvania and Washington in the United States, and Quebec in Canada. It has data campuses in Moses Lake, Panther Creek, Sharon, Sherbrooke, and Scrubgrass.

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. It operates in one segment, focusing on innovating, developing, and commercializing therapies using its autologous TIL cell therapies for patients with solid tumor cancers. Geographically, the company operates in United States and Rest of the World.

Share on Social Networks: